Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in NVAX — Novavax Inc

CIK 923093 STAMFORD, CT

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,181,908
+$132,996 QoQ
Shares Held
125,468
-2.6% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 263 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Derivatives in NVAX

reported options exposure · as of Jun 30, 2026
CallValue
$4,115,598
CallShares
436,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. NVAX ranks #51 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,115,598 436,900
2026-06-30 $1,181,908 125,468
2026-03-31 $1,048,912 128,859
2024-03-31 $177,003 37,030
2023-06-30 $91,307 12,289
2022-12-31 $479,294 46,624
2022-09-30 $708,526 38,930
2022-06-30 $3,402,145 66,151
2022-03-31 $3,481,067 47,265
2021-12-31 $556,685 3,891
2021-09-30 $1,888,386 9,109
2021-06-30 $2,002,720 9,433